Evidence map›Paper›PMID 33779897›Full record

ArticleJournal of clinical immunology2021

A Minimal Parameter Set Facilitating Early Decision-making in the Diagnosis of Hemophagocytic Lymphohistiocytosis.

Bas M Smits, Joris van Montfrans, Samuel A Merrill, Lisette van de Corput, Mariëlle van Gijn, Andrica de Vries, Cor van den Bos, Floor Abbink, Renate G van der Molen, Natasja Dors and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of clinical immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. The ability of CD4Immunologic research · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 3 countries.

Bas M SmitsCenter of Translational Immunology, University Medical Center Utrecht, Heidelberglaan 100, 3584CX, Utrecht, The Netherlands.
Joris van MontfransDepartment of Pediatric Immunology and Infectious Diseases, UMC Utrecht, Utrecht, The Netherlands.
Samuel A MerrillDivision of Hematology/Oncology, West Virginia University, Morgantown, WV, USA.
Lisette van de CorputCenter of Translational Immunology, University Medical Center Utrecht, Heidelberglaan 100, 3584CX, Utrecht, The Netherlands.
Mariëlle van GijnCenter of Translational Immunology, University Medical Center Utrecht, Heidelberglaan 100, 3584CX, Utrecht, The Netherlands.
Andrica de VriesDepartment of Pediatric Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Cor van den BosPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Floor AbbinkDepartment of Pediatric Oncology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Renate G van der MolenDepartment of Laboratory Medicine, Laboratory for Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Natasja DorsPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Caroline LindemansPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Jaap J BoelensCenter of Translational Immunology, University Medical Center Utrecht, Heidelberglaan 100, 3584CX, Utrecht, The Netherlands.
Stefan NierkensCenter of Translational Immunology, University Medical Center Utrecht, Heidelberglaan 100, 3584CX, Utrecht, The Netherlands. s.nierkens@umcutrecht.nl.ORCID 0000-0003-3406-817X
Heidelberg University · DEPrincess Máxima Center · NLRadboud University Nijmegen · NLAmsterdam University Medical Centers · NLErasmus MC · NLMemorial Sloan Kettering Cancer Center · USUniversity Medical Center Utrecht · NLWest Virginia University · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening immune dysregulation syndrome characterized by uncontrolled immune cell activation. Timely diagnosis is important, since early treatment can improve survival rates. However, completing all assessments needed to reach ≥5 positive criteria out of the 8 HLH-2004 criteria can be time consuming and may delay timely initiation of treatment. Hence, we applied a data-driven approach to identify a minimal parameter set for early decision-making towards the initiation of HLH-specific treatment. We retrospectively evaluated 165 patients from five Dutch tertiary hospitals with suspected HLH. Sixteen pHLH (median age 0.5 years) and 70 sHLH patients (median age 8.7 years) were identified using the HLH-2004 criteria. Clustering analysis and multi-receiver operator characteristics were used to identify parameters distinctive of HLH. The presence of either increased ferritin, cytopenia in ≥2 lineages, or splenomegaly distinguished HLH from non-HLH cases with a negative predictive value of 100%. A minimal parameter set consisting of 2 major criteria (phagocytosis and splenomegaly) and 3 minor criteria (cytopenia, increased ferritin, and increased triglycerides/low fibrinogen) predicted HLH with 95% (88-99) sensitivity and 94% (86-98) specificity. This finding was replicated in an independent retrospective validation cohort of 109 US patients (n = 109). By dividing a subset of the HLH-2004 criteria into major and minor criteria, this strategy uses the evaluation of less than 5 criteria to quickly identify patients with HLH. When confirmed in a prospective setting, this approach could be of value for timely diagnosis and treatment of HLH.

Indexed as

AdolescentAdultAgedAged, 80 and overCell Line, TumorChildChild, PreschoolFemaleHumansInfantInfant, NewbornK562 CellsLymphohistiocytosis, HemophagocyticMaleMiddle AgedPredictive Value of Testsclustering analysisdiagnostic criteriahemophagocytic lymphohistiocytosisHLH

Identifiers

PMID33779897
PMCPMC8310853
OpenAlexW3140180978

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.